Bellone S - Search Results

1

PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas.

Black JD, Lopez S, Cocco E, Bellone S, Altwerger G, Schwab CL, English DP, Bonazzoli E, Predolini F, Ferrari F, Ratner E, Silasi DA, Azodi M, Schwartz PE, Santin AD. Black JD, et al. Among authors: bellone s. Br J Cancer. 2015 Dec 1;113(11):1641. doi: 10.1038/bjc.2015.388. Br J Cancer. 2015. PMID: 26625219 Free PMC article. No abstract available.

2

Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer.

Santin AD, Bellone S, Ravaggi A, Roman JJ, Pecorelli S, Parham GP, Cannon MJ. Santin AD, et al. Among authors: bellone s. Br J Cancer. 2002 Jan 7;86(1):151-7. doi: 10.1038/sj.bjc.6600026. Br J Cancer. 2002. PMID: 11857027 Free PMC article.

3

Overexpression of HER-2/neu in uterine serous papillary cancer.

Santin AD, Bellone S, Gokden M, Palmieri M, Dunn D, Agha J, Roman JJ, Hutchins L, Pecorelli S, O'Brien T, Cannon MJ, Parham GP. Santin AD, et al. Among authors: bellone s. Clin Cancer Res. 2002 May;8(5):1271-9. Clin Cancer Res. 2002. PMID: 12006548

4

The novel serine protease tumor-associated differentially expressed gene-15 (matriptase/MT-SP1) is highly overexpressed in cervical carcinoma.

Santin AD, Cane' S, Bellone S, Bignotti E, Palmieri M, De Las Casas LE, Anfossi S, Roman JJ, O'Brien T, Pecorelli S. Santin AD, et al. Among authors: bellone s. Cancer. 2003 Nov 1;98(9):1898-904. doi: 10.1002/cncr.11753. Cancer. 2003. PMID: 14584072 Free article.

5

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling.

Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Gokden M, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, Shaughnessy J Jr, Pecorelli S. Santin AD, et al. Among authors: bellone s. Br J Cancer. 2004 May 4;90(9):1814-24. doi: 10.1038/sj.bjc.6601791. Br J Cancer. 2004. PMID: 15208622 Free PMC article.

6

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.

Santin AD, Bellone S, Siegel ER, Palmieri M, Thomas M, Cannon MJ, Kay HH, Roman JJ, Burnett A, Pecorelli S. Santin AD, et al. Among authors: bellone s. Am J Obstet Gynecol. 2005 Mar;192(3):813-8. doi: 10.1016/j.ajog.2004.10.605. Am J Obstet Gynecol. 2005. PMID: 15746676

7

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy.

Santin AD, Zhan F, Cane' S, Bellone S, Palmieri M, Thomas M, Burnett A, Roman JJ, Cannon MJ, Shaughnessy J Jr, Pecorelli S. Santin AD, et al. Among authors: bellone s. Br J Cancer. 2005 Apr 25;92(8):1561-73. doi: 10.1038/sj.bjc.6602480. Br J Cancer. 2005. PMID: 15785748 Free PMC article.

8

Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.

Santin AD, Diamandis EP, Bellone S, Soosaipillai A, Cane S, Palmieri M, Burnett A, Roman JJ, Pecorelli S. Santin AD, et al. Among authors: bellone s. Clin Cancer Res. 2005 May 1;11(9):3320-5. doi: 10.1158/1078-0432.CCR-04-2528. Clin Cancer Res. 2005. PMID: 15867230 Free article.

9

Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization.

Santin AD, Bellone S, Van Stedum S, Bushen W, De Las Casas LE, Korourian S, Tian E, Roman JJ, Burnett A, Pecorelli S. Santin AD, et al. Among authors: bellone s. Gynecol Oncol. 2005 Jul;98(1):24-30. doi: 10.1016/j.ygyno.2005.03.041. Gynecol Oncol. 2005. PMID: 15894362

10

Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.

Santin AD, Cané S, Bellone S, Palmieri M, Siegel ER, Thomas M, Roman JJ, Burnett A, Cannon MJ, Pecorelli S. Santin AD, et al. Among authors: bellone s. Cancer Res. 2005 May 15;65(10):4334-42. doi: 10.1158/0008-5472.CAN-04-3472. Cancer Res. 2005. PMID: 15899825 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters